Keyphrases
Antiproliferative Activity
100%
Taxol
100%
HepG2 Cells
100%
Apoptotic Activity
100%
Human CYP3A4
100%
P-glycoprotein Transporter
100%
Cytochrome P450 3A4 (CYP3A4)
42%
P-glycoprotein (P-gp)
28%
Monoclonal Antibody
14%
Apoptosis
14%
Overexpressing
14%
Protein Level
14%
MRNA Level
14%
Drug Treatment
14%
Drug-induced
14%
Morphological Changes
14%
Enzymatic Activity
14%
M Phase
14%
Hepatoma Cells
14%
Necrotic Cell Death
14%
Pre-incubation
14%
Co-incubation
14%
P-glycoprotein Expression
14%
Multidrug Resistance Protein 1 (MDR1)
14%
Ketoconazole
14%
Cycle Threshold
14%
Change Characteristics
14%
Cytochrome c Release
14%
CYP3A4 Inhibition
14%
Saturation Level
14%
Toxicity Activity
14%
Pump Efficiency
14%
Neuroscience
Paclitaxel
100%
ABC Transporter Subfamily B
100%
Cytochrome P450 3A4
100%
Cell Cycle
28%
Cell Death
14%
Cytochrome C
14%
Monoclonal Antibody
14%
Cell Cycle M Phase
14%
Enzyme Activity
14%
Multidrug Resistance Protein 1
14%
Mitosis
14%
Messenger RNA
14%
Ketoconazole
14%
Agricultural and Biological Sciences
CYP3A4
100%
P-Glycoprotein
100%
Paclitaxel
100%
Cell Cycle
28%
Monoclonal Antibody
14%
Programmed Cell Death
14%
Cytochrome C
14%
Cytosol
14%
Cell Death
14%
Messenger RNA
14%
Enzyme Activity
14%
Mitosis
14%
Pharmacology, Toxicology and Pharmaceutical Science
Paclitaxel
100%
P-Glycoprotein
100%
CYP3A4
100%
Pharmacotherapy
14%
Cytochrome C
14%
Monoclonal Antibody
14%
Ketoconazole
14%
Hepatoblastoma
14%
Multidrug Resistance Protein 1
14%
Messenger RNA
14%
Veterinary Science and Veterinary Medicine